4 Patents
- 0 cites
- US120311332024GNAQ Targeted Dsrna Compositions and Methods for Inhibiting Expression
Alnylam Pharmaceuticals, Inc.
0 cites - US118278832023Dosages and Methods for Delivering Lipid Formulated Nucleic Acid Molecules
Alnylam Pharmaceuticals, Inc.
0 cites - US118063602023Compositions and Methods for Treating Transthyretin (TTR) Mediated Amyloidosis
Alnylam Pharmaceuticals, Inc.
0 cites